AzTrials
AzTrials

Vascular MalformationsNCT04637997

Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations

A study testing compression stockings class I and compression stockings class II in people with Vascular Malformations and Vascular Malformation Peripheral, run by University Hospital Erlangen at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Diseases with vascular malformations are rare and often congenital, affecting patients of all ages. Depending on their extent and localization, they can cause discomfort and, especially if activity is restricted, lead to loss or reduced quality of life. Read more about this study

Who is it for?
Any age
What is being tested?
compression stockings class I and compression stockings class II
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteGermany
Study dates
1 Oct 2017to 1 Oct 2020
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Patients with a confirmed venous malformation of the upper/lower extremity independent of previous therapy with epi- and/or subfascial localization of the venous malformation independent of the local extent (cross-articular or not)
  • Compression stocking can be put on independently or by the parents
  • Written declaration of consent present

Who cannot join

  • Lack of compliance, patient is not available for control appointments
  • Additional drug therapy (anticoagulation) for extensive venous malformations with threatening thromboembolic complications
  • Known allergic reaction/intolerance to components of flat-knitted compression stockings
  • Pregnancy
  • Rejection of the study participation by the patient
  • Contraindications for the planned MRI examination (pacemakers, implants not suitable for MRI, claustrophobia)
Show all 9Show fewer
  • Occurrence of an emergency situation
  • Severe heart failure as contraindication for compression therapy
  • Peripheral arterial disease as contraindication for compression therapy

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Hospital of Erlangen, Vascular Surgery

    Erlangen, 91054

Other trials in Germany

About this study

Official title: Influence of Flat-knitted Compression Stockings Class I and II on the Morphology of Venous Malformations - Is There a Therapeutic Effect?

Diseases with vascular malformations are rare and often congenital, affecting patients of all ages. Depending on their extent and localization, they can cause discomfort and, especially if activity is restricted, lead to loss or reduced quality of life.

The therapy is usually reserved for a few specialized centers and includes interventional sclerotherapy as well as conservative therapy by compression with appropriate compression stockings. However, there are currently no study-based recommendations for this approach.

Read more

The aim of this study is to prove a therapeutic effect of compression therapy using flat-knitted compression stockings on venous malformations of the extremities and to derive from this a therapy recommendation in connection with an improvement in the health status and quality of life.

For this purpose, patients with a confirmed venous malformation of the upper or lower extremity independent of previous therapy will be included. We will investigate patients with epi- and/or subfascial localization of the venous malformation independent of the local extent (cross-articular or not).

Being tested
compression stockings class I, compression stockings class II
Keywords
Compression therapy, Compression stockings class I, Compression stockings class II, Short-Form 12 (SF-12), Quality of life, Wearing comfort, Magnetic Resonance Imaging, MRI, Perometre
Medical subject headings
Vascular Malformations, Vascular Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • compression stockings class IDevice

    Daily wearing of compression stockings class I for four weeks on the affected extremity.

  • compression stockings class IIDevice

    Daily wearing of compression stockings class II for four weeks on the affected extremity.

Study groups in NCT04637997
Study groupRoleWhat they receive
Study group 1OtherWearing of compression stockings class I between Investigation day 28 to 56. Wearing of compression stockings class II between Investigation day 56 to 84.
Receives: Device: compression stockings class I; Device: compression stockings class II
Study group 2OtherWearing of compression stockings class II between Investigation day 28 to 56. Wearing of compression stockings class I between Investigation day 56 to 84.
Receives: Device: compression stockings class I; Device: compression stockings class II

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Volume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRI

    Determination and comparison of volume difference of the malformation after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by MRI.

    Measured: one day

  2. Volume Difference of the Affected Extremity to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by Perometre

    Determination and comparison of volume difference of the affected extremity after application of compression stockings class I and II compared to baseline (no compression) measured non-invasively by perometre.

    Measured: one day

Secondary outcomes (1)
  1. Difference Between Quality of Life at Baseline (no Compression at Day 28) and Compression Classes I and II by Short Form-12 (SF-12) Health Survey at Day 56 or 84

    SF-12v2 (SOEP-Version 2004) scale is a generic, multipurpose short-form survey with 12 questions selected from the SF-36 Health Survey which, when combined, scored and weighted, results in two scales of mental (MCS) and physical (PCS) functioning and overall health-related quality of life.

    A higher value indicates a better quality of life of the patient. The scores range from 0 to 100. The overall mean for each scale is 50 points and the standard deviation is 10 points in the SOEP sample.

    Measured: up to two months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Nov 2020
  2. Study start1 Oct 2017
  3. Primary completion1 Mar 2019
  4. Study completion1 Oct 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
This is a single group study with crossover components. Participants receive randomly and double-blinded either class I compression stockings or class II compression stockings. After four weeks, an exchange of compression classes takes place, so that all participants wear both classes of compression stockings within eight weeks.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04637997
Sponsor's protocol ID
VM_Compression
Status last verified
Mar 2021
First submitted
9 Nov 2020
Last updated
16 Mar 2021
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing compression stockings class I and compression stockings class II in people with Vascular Malformations and Vascular Malformation Peripheral, run by University Hospital Erlangen at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 16 Mar 2021). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Volume Difference of Malformation to Baseline (no Compression) While Wearing Compression Stockings Class I and II Determined by MRI (time frame: one day). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Mar 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in